UCL Global Business School for Health, the world’s first business school dedicated to health, has announced a new scholarship with Bupa, a leading global healthcare company.
The new scholarship — including a fully funded MBA place and living cost stipend, which is worth more than £65,000 — will enable a UK student from a disadvantaged background to join UCL Global Business School for Health’s MBA Health programme.
The scholarship will be awarded based on financial need, helping to ensure that future health leaders can access world-class education regardless of their background.
The MBA Health programme provides students with the knowledge, skills and experience to understand and lead complex healthcare systems around the world. From tackling major public health challenges like ageing populations, to controlling major multi-million pound budgets in hospital trusts, students will be prepared for careers in both the NHS and in healthcare organisations around the world.
The student funded by the scholarship will begin their studies in September 2025, and Bupa and UCL Global Business School for Health plan to develop their partnership over the year ahead.
Dr Oskana Gerwe, MBA Director at UCL Global Business School for Health, said: “We’re incredibly proud to be working with Bupa, and the impact of this scholarship in helping to develop future healthcare leaders will be significant. For nearly 80 years Bupa has been at the forefront of delivering healthcare around the world, and it is fantastic that the next generation of health leaders will be able to draw on their generosity.”
Dr Anne Lepetit, Group Chief Medical Officer at Bupa said: “We are proud to partner with the world-renowned UCL to invest in the future of healthcare leadership. This scholarship reflects our deep commitment to developing the clinical workforce of tomorrow able to challenge, question and think differently to pursue excellence. We are truly excited to support passionate, inspired individuals on their journey to make a lasting impact in healthcare.”
Dr Gargi Banerjee awarded £2 million MRC Clinician Scientist Fellowship
Dr Gargi Banerjee (MRC Prion Unit at UCL) has received the prestigious fellowship to support her research which aims to better understand amyloid-related diseases such as Alzheimer's disease.
20 Jun 2025
New study targets neurocomputational root cause of depression’s most debilitating symptom: Anergia
An international team will study why effort feels overwhelming in depression, using neuroscience and AI to develop better treatments for anergia.
20 Jun 2025
BSL GCSE: New CPD Courses for Deaf Teachers
Calling all deaf teachers!
19 Jun 2025